J. D. Montejo Hernández, “Evidence-based Colombian consensus and expert opinion regarding the use of sodium-glucose cotransporter type 2 (iSGLT-2) inhibitors in the cardiorenal continuum in patients with chronic kidney disease”, Rev. Colomb. Nefrol., vol. 12, no. 2, May 2025.